您的位置: 首页 > 农业专利 > 详情页

Cepiva proti okuĹľbi humanega citomegalovirusa z optimizacijo kodona, ki temeljijo na polinukleotidu
专利权人:
VICAL INCORPORATED
发明人:
HERMANSON GARY G.,GEALL ANDREW J.,WLOCH MARY KOPKE,Hermanson Gary G.,Geall Andrew J.,Wloch Mary Kopke
申请号:
SI200332305
公开号:
SI2311848T1
申请日:
2003.12.19
申请国别(地区):
SI
年份:
2013
代理人:
摘要:
The invention is related to polynucleotide-based cytomegalovirus vaccines. In particular, the invention is plasmids operably encoding HCMV antigens, in which the naturally-occurring coding regions for the HCMV antigens have been modified for improved translation in human or other mammalian cells through codon optimization. HCMV antigens which are useful in the invention include, but are not limited to pp65, glycoprotein B (gB), IEI, and fragments, variants or derivatives of either of these antigens. In certain embodiments, sequences have been deleted, e.g., the Arg435-Lys438 putative kinase in pp65 and the membrane anchor and endocellular domains in gB. The invention is further directed to methods to induce an immune response to HCMV in a mammal, for example, a human, comprising delivering a plasmid encoding a codon-optimized HCMV antigen as described above. The invention is also directed to pharmaceutical compositions comprising plasmids encoding a codon-optimized HCMV antigen as described above, and further comprising adjuvants, excipients, or immune modulators.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充